Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-17-012183
Filing Date
2017-09-11
Accepted
2017-09-11 20:11:08
Documents
2
Period of Report
2017-09-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 3439
2 POWER OF ATTORNEY ex24kroeger.txt EX-24 3993
  Complete submission text file 0001179110-17-012183.txt   8754
Mailing Address 9 FOURTH AVE WALTHAM MA 02451
Business Address 9 FOURTH AVE WALTHAM MA 02451 617-500-2802
OvaScience, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CANTEX PHARMACEUTICALS, INC. 1792 BELL TOWER LANE WESTON FL 33326
Business Address
Kroeger Christopher A. (Reporting) CIK: 0001658918 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35890 | Film No.: 171079937